POSA236 Real-World Treatment (Tx) Characteristics for Advanced Non-Small Cell Lung Cancer (aNSCLC) Without Actionable Mutations After Introduction of Immune Checkpoint Inhibitors (ICIs) in EU4 and UK

Autor:	J Multani, V Casey, S Mpima, M Yasuda, CC Chen, F Manuguid, L Kalilani, TJ Giove, J Chao, A Aziez, A Stojadinovic, C Hogea
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S154-S155
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.11.751
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::18d9037289800497b02e17e65ec8385d https://doi.org/10.1016/j.jval.2021.11.751 Zobrazit plný text záznamu Full Text from ScienceDirect